In this interview, Dr. Denise Heaney discusses how molecular diagnostics are reshaping antimicrobial stewardship and redefining the standard of care for infectious diseases.
Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...
Concourse Plaza Multiplex Cinemas in the Bronx is closing its curtains for good Tuesday night after more than three decades in business. In a statement, the movie theater on East 161st Street in ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
ProbeLibrary, a fast, specific and flexible format for quantitative real-time PCR, is described. The ProbeLibrary concept is based on the fact that just 90 short probes provide transcriptome-wide ...
With its COMET fluorescence-integrated staining and imaging instrument, Lunaphore Technologies is making it possible for any laboratory to take advantage of the deep insights offered by analyzing the ...